Great Lakes Advisors’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-104,322
| Closed | -$772K | – | 830 |
|
|
2024
Q4 | $772K | Sell |
104,322
-7,758
| -7% | -$57.4K | 0.01% | 603 |
|
|
2024
Q3 | $1.05M | Sell |
112,080
-13,423
| -11% | -$126K | 0.01% | 579 |
|
|
2024
Q2 | $1.01M | Sell |
125,503
-3,481
| -3% | -$27.9K | 0.01% | 574 |
|
|
2024
Q1 | $1.91M | Sell |
128,984
-7,199
| -5% | -$107K | 0.02% | 475 |
|
|
2023
Q4 | $1.11M | Sell |
136,183
-140,351
| -51% | -$1.14M | 0.01% | 518 |
|
|
2023
Q3 | $1.26M | Sell |
276,534
-7,647
| -3% | -$34.8K | 0.01% | 500 |
|
|
2023
Q2 | $2M | Sell |
284,181
-75,043
| -21% | -$528K | 0.02% | 445 |
|
|
2023
Q1 | $2.19M | Buy |
+359,224
| New | +$2.19M | 0.02% | 487 |
|